An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria-Reference-Cited by-同舟云学术

An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria

Published:2016-07-18 Issue:2 Volume:28 Page:494-503
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Liebow Abigail,Li Xingsheng,Racie Timothy,Hettinger Julia,Bettencourt Brian R.,Najafian Nader,Haslett Patrick,Fitzgerald Kevin,Holmes Ross P.,Erbe David,Querbes William,Knight John

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference32 articles.

1. An update on primary hyperoxaluria

2. Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria

3. End-stage renal disease of the Tunisian child: epidemiology, etiologies, and outcome

4. End-stage renal disease in Kuwaiti children: An 8-year experience

5. AGXT Gene Mutations and Prevalence of Primary Hyperoxaluria Type 1 in Moroccan Population

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1: Results from a Phase III Clinical Trial;Kidney International Reports;2024-07

2. Liver gene transfer for metabolite detoxification in inherited metabolic diseases;FEBS Letters;2024-06-17

3. Navigating the Evolving Landscape of Primary Hyperoxaluria: Traditional Management Defied by the Rise of Novel Molecular Drugs;Biomolecules;2024-04-23

4. Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs;Communications Biology;2024-04-23

5. A review of animal models utilized in preclinical studies of approved gene therapy products: trends and insights;Laboratory Animal Research;2024-04-22